• RAB Proximity Mapping Reveals RAB14 Functions

  2026-08-12

  Gaudreault and colleagues used APEX2 proximity labeling to map proteins neighboring 23 human RAB GTPases and identify trafficking-associated functional relationships. The study highlights RAB14 links to the EARP complex and SHIP164/UHRF1BP1, while also defining a RAB25–DENND6A connection relevant to recycling endosomes.

• Cy3-dCTP for Direct DNA Labeling

  2026-08-12

  Cy3-dCTP enables direct fluorescent incorporation into DNA and cDNA for PCR, Nick Translation, and hybridization workflows. This practical guide connects reaction design, probe-generation choices, and troubleshooting with emerging lessons from structured enzymatic DNA synthesis.

• SB-505124 Hydrochloride: Research Workflows

  2026-08-11

  Translate selective ALK4/5/7 inhibition into practical assays for Smad signaling, fibroblast activation, glaucoma models, and cancer mechanobiology. This guide combines solvent handling, dose-finding, pathway readouts, and troubleshooting for more interpretable SB-505124 experiments.

• MTT Readouts for Translational GBM Research

  2026-08-11

  A mechanistic and strategic guide to using MTT as a metabolic readout in glioblastoma nanomedicine studies, with practical controls, translational limitations, and a framework for connecting cell viability data to immune-cycle outcomes.

• Tranexamic Acid Workflows for Clot Stability

  2026-08-10

  Build reproducible clot-stabilization, plasmin, and cell-adhesion assays with Tranexamic Acid, an antifibrinolytic agent suited to mechanistic fibrinolysis research. Translate the published NO–Tranexamic Acid–propolis dressing design into practical formulation screens while keeping antibacterial effects and antifibrinolytic effects analytically separate.

• CCG-1423: Rethinking RhoA Pathway Translation

  2026-08-09

  RhoA signaling is not a single switch but a layered network spanning cytoskeletal mechanics, nuclear transcription, barrier integrity, invasion, and apoptosis. This article examines how CCG-1423 can help translational researchers separate MRTF-A nuclear signaling from RhoA/ROCK-driven contractility, using recent MVC infection findings to define opportunities, controls, and limitations.

• Alpha-2 Receptors Link Itch and Pain via the Locus Coeruleus

  2026-08-08

  The reference study identifies the descending locus coeruleus–spinal cord noradrenaline pathway as a circuit that oppositely regulates itch and pain through α2 adrenergic receptors. Its comparison of locus coeruleus noradrenergic neurons with their spinal projection provides a useful framework for interpreting circuit-specific chemogenetic and pharmacological experiments.

• CircCramp1l–HMGB1/Drp1 Axis in Allergic Rhinitis

  2026-08-07

  A 2026 Biochemical Pharmacology study identifies circCramp1l as an upstream regulator of mitochondrial dysfunction and allergic inflammation through the miR-532-3p/HMGB1/Drp1 pathway. Its combination of human tissue, HDM models, multi-omics, molecular interaction assays, and genetic and pharmacological rescue experiments provides a mechanistic framework for studying allergic rhinitis.

• Cy5 Goat Anti-Rabbit IgG (H+L) Antibody: Signal Amplificatio

  2026-08-07

  Explore how the Cy5 Goat Anti-Rabbit IgG (H+L) Antibody empowers advanced detection in antiviral innate immunity research. This in-depth guide unpacks fluorescence signal amplification and practical protocol insights for dissecting MAVS regulation, offering a perspective beyond typical workflow articles.

• Aminopeptidase Inhibition as an Antimalarial Strategy: Insig

  2026-08-06

  The referenced study establishes phebestin, a bestatin-related aminopeptidase inhibitor, as a potent antiplasmodial agent active against both chloroquine-sensitive and -resistant Plasmodium falciparum strains. This innovation underscores aminopeptidases as validated drug targets and provides a foundation for developing therapies that may circumvent current resistance issues in malaria.

• SAR131675: VEGFR-3 Inhibitor for Advanced Fibrosis & Cancer

  2026-08-06

  SAR131675 enables precise, high-selectivity targeting of VEGFR-3-driven lymphangiogenesis and angiogenesis, unlocking robust modeling in fibrotic and oncology research. Its nanomolar potency and protocol-proven selectivity streamline both mechanistic and translational workflows, as highlighted by recent breakthroughs in hepatic fibrosis and tumor microenvironment studies.

• Dibutyryl-cAMP, Sodium Salt: Enhancing cAMP Pathway Research

  2026-08-05

  Dibutyryl-cAMP, sodium salt empowers researchers to precisely modulate intracellular cAMP levels, enabling robust protein kinase A assays and advanced neuronal reprogramming workflows. This guide bridges foundational principles with hands-on troubleshooting and showcases how APExBIO’s rigorously validated B9001 product accelerates reproducible, high-impact discoveries.

• Flumequine as a Research-Grade DNA Topoisomerase II Inhibito

  2026-08-05

  Explore the advanced scientific underpinnings of Flumequine, a potent DNA topoisomerase II inhibitor, and discover how its unique properties empower precision DNA replication and cancer research. This article sheds light on nuanced assay design and practical limitations, setting it apart from existing guides.

• Afatinib (BIBW 2992): Driving Precision in Tumor-Stroma Mode

  2026-08-04

  Explore how Afatinib empowers advanced cancer biology research by irreversibly targeting ErbB kinases in patient-derived tumor-stroma models. This article offers novel insights into optimizing assembloid assays and overcoming resistance mechanisms.

• Canagliflozin Hemihydrate in Glucose Metabolism Research Wor

  2026-08-04

  Canagliflozin hemihydrate empowers metabolic disorder research with precise SGLT2 inhibition, enabling high-fidelity modeling of renal glucose reabsorption and homeostasis. This guide reveals protocol enhancements, key study results, and troubleshooting strategies that differentiate Canagliflozin from mTOR pathway inhibitors in advanced glucose metabolism assays.

15678 records 1/1046 page Next 12345 下5页 Last page